Adjunctive treatment with subantimicrobial doses of doxycycline: effects on gingival fluid collagenase activity and attachment loss in adult periodontitis

Journal of Clinical Periodontology - Tập 28 Số 2 - Trang 146-156 - 2001
Lorne M. Golub1, T. F. McNamara1, Maria Emanuel Ryan1, Bruce Kohut2,3, Timothy M. Blieden4, Gregory Payonk5, Tibor Sipos2,6, Hazen J. Baron2,7
1Department of Oral Biology and Pathology, School of Dental Medicine, State University of New York at Stony Brook, Stony Brook, NY
2Previously, Johnson and Johnson Consumer Products, Skillman, NJ
3currently, Warner Lambert Company, Morris Plains, NJ
4Department of Periodontology, Eastman Dental Center, Rochester, NY
5Johnson and Johnson Consumer Products, Skillman, NJ
6currently, Digestive Care Inc, Bethlehem, PA
7currently, consultant, Morristown, NJ, USA

Tóm tắt

AbstractObjectives: The therapeutic effects of doxycycline and other tetracyclines in the treatment of periodontitis involve, at least in part, mechanisms that are unrelated to their antimicrobial activity. Previous clinical studies have shown that doxycycline administered orally, at doses below those needed for antimicrobial efficacy, to human subjects with adult periodontitis resulted in significantly reduced collagenase activity in gingival crevicular fluid (GCF) and in extracts of inflamed gingival tissues. The purpose of the present study was to identify clinically effective dosing regimens using subantimicrobial dose doxycycline (SDD) as an adjunctive therapy in patients with adult periodontitis.Material and Methods: A total of 75 adult men and women qualified for enrollment into the three‐part, placebo‐controlled, double‐blind, parallel‐group study. Patients were stratified based on repeatedly exhibiting pathologic levels of periodontal attachment (ALv) and GCF collagenase activity at several appointments prior to baseline. Patients were administered a scaling and prophylaxis, then 1 of 5 treatment schedules for 12 weeks (part I), followed by a 12‐week period of no drug therapy (part II), a second scaling and prophylaxis, and 12 additional weeks of treatment (part III). Primary determinants of efficacy included reductions in GCF collagenase activity and changes in relative ALv.Results: 66 patients completed the 1st 12 weeks (part I) of the 3‐part, 36‐week study; 51 patients completed the entire 36‐week study. From baseline to week 12 (part I), treatment with specially formulated SDD capsules (20 mg) 2× daily (1× every 12 h) for up to 12 weeks was shown to significantly reduce GCF collagenase activity and to improve ALv, effects not seen in patients treated with placebo. Continuous drug therapy over the 12‐week treatment period was needed to maintain and maximize the reduction in GCF collagenase and the improvement in ALv. Improvements in periodontal disease parameters occurred without the emergence of doxycycline‐resistant micro‐organisms. In patients administered an “on‐off‐on” regimen of SDD over 36 weeks (parts I–III), essentially no attachment loss occurred in patients receiving the highest of these SDD regimens (20 mg 2× daily during part I and 20 mg 1× daily in part III), whereas patients administered placebo capsules experienced a mean attachment loss of approximately 0.8 mm at the 24‐ and 36‐week time periods.Conclusions: Doxycycline administered at subantimicrobial doses led to improvements in disease parameters, with no apparent side effects, and appears to have significant potential as an oral adjunctive therapy in the long‐term management of adult periodontitis.

Từ khóa


Tài liệu tham khảo

Caton J. G., 1985, The Interdental Bleeding Index: A simplified procedure for monitoring gingival health., The Compendium of Continuing Education in Dentistry, 88

Caton J. G., 1999, Evaluation of Periostat® for patient management., Compendium of Continuing Education in Dentistry, 20, 451

Ciancio S., 1989, Gingival crevicular fluid collagenolytic activity in diagnosing periodontal disease., Journal of Dental Research, 68, 334

10.1902/jop.1996.67.5.506

10.1111/j.1600-051X.1997.tb01837.x

10.1177/00220345960750121101

Fisher L. D., 1993, Biostatistics, a methodology for the health sciences,, 611

10.1177/10454411900010010501

10.1111/j.1399-302X.1986.tb00324.x

10.1111/j.1600-051X.1988.tb01008.x

10.1111/j.1600-0765.1990.tb00923.x

10.1111/j.1749-6632.1994.tb24728.x

10.1902/jop.1985.56.11s.93

10.1007/s000110050193

10.1111/j.1600-0765.1983.tb00388.x

10.1177/08959374980120010501

10.1177/00220345870660080401

10.1177/10454411910020030201

10.1111/j.1600-051X.1995.tb00120.x

10.1111/j.1600-0765.1985.tb00405.x

10.14219/jada.archive.1994.0261

10.1111/j.1749-6632.1994.tb24734.x

10.1016/s8756-3282(97)00221-4

10.1902/jop.1986.57.1.14

Hancock E. B., 1994, Antimicrobials in periodontal practice., Dental Clinics of North America, 38, 719, 10.1016/S0011-8532(22)00186-0

10.1902/jop.1993.64.2.82

Landsberger H. A., 1958, Hawthorne revisited.

10.1111/j.1600-0765.1997.tb01377.x

Listgarten M. A., 1984, A reevaluation of selected diagnostic techniques: potential influence on the clinical practice of periodontics., Journal of the Canadian Dental Association, 50, 549

10.3109/00016356309011240

10.1111/j.1600-051X.1988.tb01567.x

10.1111/j.1600-051X.1990.tb01682.x

10.1111/j.1600-0765.1987.tb01595.x

Osborn J., 1989, Relative clinical attachment loss measurements using a Florida Disk Probe., Journal of Dental Research, 68, 360

10.1111/j.1749-6632.1994.tb24733.x

Roethlisberger F. J., 1939, Management and the worker.

Seymour R. A., 1997, Pharmacological control of periodontal disease (II). Antimicrobial agents., Journal of Dentistry, 24, 237

Slots J., 1977, Microflora in the healthy gingival sulcus in man., Scandinavian Journal of Dental Research, 85, 247

10.1111/j.1600-051X.1986.tb00849.x

10.1111/j.1600-051X.1988.tb00999.x

Slots J., 1993, Antimicrobial therapy in periodontics., Journal of the California Dental Association, 21, 51

Smith G. N., 1996, Inhibition by doxycycline of a truncated form of recombinant MMP‐13., Arthritis and Rheumatism, 39, S226

10.1111/j.1600-0765.1988.tb01618.x

10.1111/j.1600-051X.1985.tb01401.x

Thomas J., 1998, Effect of sub‐antimicrobial dose doxycycline on periodontal microbial resistance., Journal of Dental Research, 77, 795

10.1177/08959374980120011601

Uitto V. J., 1998, Collagenase‐3 (matrix metalloproteinase‐13) expression is induced in oral mucosal epithelium during chronic inflammation., American Journal of Pathology, 152, 1489

10.1111/j.1600-0765.1987.tb01603.x

Walker C., 1998, Effect of sub‐antimicrobial dose doxycycline on periodontal flora., Journal of Dental Research, 77, 795

Walker C., 2000, Effect of sub‐antimicrobial dose doxycycline (SDD) on intestinal and vaginal flora., Journal of Dental Research, 79, 608

10.1111/j.1399-302X.1987.tb00300.x

Zambon J. J., 1986, Methodology and clinical significance of rapid assays for periodontal pathogens., Journal of Dental Research, 65, 167